2016 VAM: 1802 - Management of Atopic Dermatitis: What's New?

The course discusses possible therapeutic consequences owing to new insights into the pathogenesis of atopic dermatitis.

AMA PRA Category 1 Credits™: 1.25
CE: 1.25

Credit must be claimed by May 31, 2018.  Any credit request on or after June 1, 2018 will be subject to an administrative fee.

Target Audience

Physicians
Allergists/Immunologists
Nurses
Nurse Practitioners
Allied Health Professionals

Learning Objectives

Upon completion of this session, participants should be able to:

1.  Discuss the role of skin microbiome in atopic dermatitis
2.  Discuss patient education for atopic dermatitis
3.  Discuss possible therapeutic consequences owing to new insights into the pathogenesis of atopic dermatitis

Additional Information

AttachmentSize
PDF icon 2016 Annual Meeting Disclosures120.13 KB
Summary
Available credit: 
  • 1.25 Attendance
    Attendance credit.
  • 1.25 CE
    CE credit.
  • 1.25 CME
    CME credit.
Course opens: 
05/31/2016
Course expires: 
05/31/2018
Cost:
$15.00
Rating: 
0

Lisa A. Beck, MD FAAAAI, University of Rochester Medical Center, Rochester, NY
Relevant relationships: Consultant Abbvie (Ongoing): Array Biopharma (Ongoing): Celgene (Ongoing): Janssen (Ongoing): Medimmune (Ongoing): Novartis (Ongoing): Regeneron (Ongoing): Unilever. Wyeth (Ongoing): Stocks

Donald Y.M. Leung, MD PhD FAAAAI, National Jewish Health, Denver, CO
Relevant relationships:  Advisory Board: Biogen-Idec, Celgene, GSK, Galderma, Novartis, Regeneron, Sanofi.

Dagmar Simon, MD, University Hospital Bern, Bern, Switzerland 
Relevant relationships: None


Annual Meeting sessions and faculty were reviewed by members of the Practice Improvement Subcommittee.  Disclosures are located in the 2016 Annual Meeting Disclosures PDF. 
 

Available Credit

  • 1.25 Attendance
    Attendance credit.
  • 1.25 CE
    CE credit.
  • 1.25 CME
    CME credit.

Price

Cost:
$15.00
Please login or register to take this course.

Required Hardware/software

Our system supports the two most recent versions of Safari, Google Chrome, and Firefox. Internet Explorer is not recommended.